Acceptance of Telemedicine in Dermatology Patients, Physicians and Medical Staff
NCT ID: NCT04495036
Last Updated: 2020-08-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
683 participants
OBSERVATIONAL
2019-07-01
2020-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Online Question-answering and Conventional Consultation With a Dermatologist
NCT01969422
Internet and Social Media Use in Dermatology Patients
NCT03913598
Teledermatology Versus Usual Care on Delay Before Diagnosis and Treatment of Dermatologic Conditions
NCT02122432
Application of Telemedicine for Dermatological Emergency Patients
NCT02836665
Impact of COVID-19 on Occupational Dermato-allergology Consultations of Health Peronnel
NCT06237010
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
dermatology patients
data collection (21-items-patient descriptive survey)
Dermatology patients are asked to complete a 21-items-survey while waiting for the doctor's consultation. Following variables will be addressed:
* Demographic data of telemedicine users and non-users
* Subjective disease perception of the dermatology patients
* Use of internet, telemedicine and telemedicine insurance model
* Patients´ willingness for additional features of telemedicine
* Advantages and disadvantages telemedicine and face-to-face consultation
* Suitable fields of dermatology for telemedicine from the patient's perspective
* Recommended structure of telemedical services by users and non-users
physicians and medical staff
data collection (23-items-physician descriptive survey)
To obtain the view of Swiss dermatologists, other physicians and medical staff on telemedicine a 23-items-survey will be completed. Following variables will be addressed:
* Objective disease perception of the treating dermatologist (regarding the urgency of the patient's medical examination, the functional impairment and cosmetic burden due to patient's disease, the impairment of life quality due to patient's disease and the estimation of the course of the patient's disease)
* Suitable fields of dermatology for telemedicine from the physician's and medical staff's perspective
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
data collection (21-items-patient descriptive survey)
Dermatology patients are asked to complete a 21-items-survey while waiting for the doctor's consultation. Following variables will be addressed:
* Demographic data of telemedicine users and non-users
* Subjective disease perception of the dermatology patients
* Use of internet, telemedicine and telemedicine insurance model
* Patients´ willingness for additional features of telemedicine
* Advantages and disadvantages telemedicine and face-to-face consultation
* Suitable fields of dermatology for telemedicine from the patient's perspective
* Recommended structure of telemedical services by users and non-users
data collection (23-items-physician descriptive survey)
To obtain the view of Swiss dermatologists, other physicians and medical staff on telemedicine a 23-items-survey will be completed. Following variables will be addressed:
* Objective disease perception of the treating dermatologist (regarding the urgency of the patient's medical examination, the functional impairment and cosmetic burden due to patient's disease, the impairment of life quality due to patient's disease and the estimation of the course of the patient's disease)
* Suitable fields of dermatology for telemedicine from the physician's and medical staff's perspective
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* dermatologists, other physicians and medical staff of the Department of Dermatology of the Cantonal Hospital Aarau and the University Hospitals Basel and Zürich
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Basel, Switzerland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lara Valeska Maul, Dr. med.
Role: PRINCIPAL_INVESTIGATOR
Department of Dermatology, University Hospital Basel
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kantonsspital Aarau
Aarau, , Switzerland
Department of Dermatology, University Hospital Basel
Basel, , Switzerland
University Hospital Zürich
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Maul LV, Jahn AS, Pamplona GSP, Streit M, Gantenbein L, Muller S, Nielsen ML, Greis C, Navarini AA, Maul JT. Acceptance of Telemedicine Compared to In-Person Consultation From the Providers' and Users' Perspectives: Multicenter, Cross-Sectional Study in Dermatology. JMIR Dermatol. 2023 Aug 11;6:e45384. doi: 10.2196/45384.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Req-2019-00523; sp20Maul2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.